Safety and Efficacy of Liraglutide in Combination With an OAD in Subjects With Type 2 Diabetes Insufficiently Controlled on OAD Alone
Clinical trial NCT01512108 · COMPLETED
Trial details
- NCT number
- NCT01512108
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-10
- Primary completion
- 2013-04-26
- Enrollment
- 363
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.